FDA Inspection 1165390 - Nancy Kim, M.D. - March 25, 2022

Record Details

This FDA Inspection record concerns Nancy Kim, M.D., with an inspection on March 25, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Nancy Kim, M.D.
Inspection Date: March 25, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 84f7eb37-b471-4833-b776-a48eb13cb621

Violation Codes1

21 CFR 312.60

Full citation text and observation details available on the Dashboard.